Ultane (AbbVie Inc.)


Welcome to the PulseAid listing for the Ultane drug offered from AbbVie Inc.. This General Anesthesia [PE],General Anesthetic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: AbbVie Inc.
NON-PROPRIETARY NAME: Sevoflurane
SUBSTANCE NAME: SEVOFLURANE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: General Anesthesia [PE],General Anesthetic [EPC]
ROUTE: RESPIRATORY (INHALATION)
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1995-06-07
END MARKETING DATE: 0000-00-00


Ultane HUMAN PRESCRIPTION DRUG Details:

Item DescriptionUltane from AbbVie Inc.
LABELER NAME: AbbVie Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 250(mL/250mL)
START MARKETING DATE: 1995-06-07
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0074-4456_14d52736-b223-d525-dfb2-a27c808adece
PRODUCT NDC: 0074-4456
APPLICATION NUMBER: NDA020478

Other SEVOFLURANE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AbbVie Inc.Ultane
Baxter Healthcare CorporationSevoflurane
Piramal Critical Care IncSojourn
Piramal Critical Care, Inc.Sevoflurane
Sandoz Inc.Sevoflurane